Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
2002 8
2003 5
2004 6
2005 9
2006 12
2007 13
2008 19
2009 12
2010 16
2011 16
2012 31
2013 28
2014 10
2015 17
2016 17
2017 15
2018 21
2019 13
2020 25
2021 12
2022 8
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

270 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study.
Schmidt ME, Kezic I, Popova V, Melkote R, Van Der Ark P, Pemberton DJ, Mareels G, Canuso CM, Fava M, Drevets WC. Schmidt ME, et al. Among authors: drevets wc. Neuropsychopharmacology. 2024 Apr 22. doi: 10.1038/s41386-024-01862-x. Online ahead of print. Neuropsychopharmacology. 2024. PMID: 38649428
Disturbed sex hormone milieu in males and females with major depressive disorder and low-grade inflammation.
Lombardo G, Mondelli V, Worrell C, Sforzini L, Mariani N, Nikkheslat N, Nettis MA, Kose M, Zajkowska Z, Cattaneo A, Pointon L, Turner L, Cowen PJ, Drevets WC, Cavanagh J, Harrison NA, Bullmore ET; Neuroimmunology of Mood Disorders and Alzheimer's Disease (NIMA) Consortium; Dazzan P, Pariante CM. Lombardo G, et al. Among authors: drevets wc. J Affect Disord. 2024 Mar 15;356:167-176. doi: 10.1016/j.jad.2024.03.018. Online ahead of print. J Affect Disord. 2024. PMID: 38494137 Free article.
Characterization of the central nervous system penetrant and selective purine P2X7 receptor antagonist JNJ-54175446 in patients with major depressive disorder.
Recourt K, de Boer P, van der Ark P, Benes H, van Gerven JMA, Ceusters M, van Nueten L, Drevets WC, Bhatacharya A, Browning M, Jacobs GE. Recourt K, et al. Among authors: drevets wc. Transl Psychiatry. 2023 Jul 24;13(1):266. doi: 10.1038/s41398-023-02557-5. Transl Psychiatry. 2023. PMID: 37482560 Free PMC article. Clinical Trial.
Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study.
Sforzini L, Cattaneo A, Ferrari C, Turner L, Mariani N, Enache D, Hastings C, Lombardo G, Nettis MA, Nikkheslat N, Worrell C, Zajkowska Z, Kose M, Cattane N, Lopizzo N, Mazzelli M, Pointon L, Cowen PJ, Cavanagh J, Harrison NA, Jones D, Drevets WC, Mondelli V, Bullmore ET; Neuroimmunology of Mood Disorders and Alzheimer’s Disease (NIMA) Consortium; Pariante CM. Sforzini L, et al. Among authors: drevets wc. Transl Psychiatry. 2023 Jun 1;13(1):185. doi: 10.1038/s41398-023-02438-x. Transl Psychiatry. 2023. PMID: 37264010 Free PMC article.
Long-term safety and maintenance of response with esketamine nasal spray in participants with treatment-resistant depression: interim results of the SUSTAIN-3 study.
Zaki N, Chen LN, Lane R, Doherty T, Drevets WC, Morrison RL, Sanacora G, Wilkinson ST, Popova V, Fu DJ. Zaki N, et al. Among authors: drevets wc. Neuropsychopharmacology. 2023 Jul;48(8):1225-1233. doi: 10.1038/s41386-023-01577-5. Epub 2023 May 12. Neuropsychopharmacology. 2023. PMID: 37173512 Free PMC article. Clinical Trial.
Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant.
Jamieson C, Popova V, Daly E, Cooper K, Drevets WC, Rozjabek HM, Singh J. Jamieson C, et al. Among authors: drevets wc. Health Qual Life Outcomes. 2023 May 8;21(1):40. doi: 10.1186/s12955-023-02113-1. Health Qual Life Outcomes. 2023. PMID: 37158911 Free PMC article. Clinical Trial.
270 results